BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22458565)

  • 1. Human parvovirus PARV4 in plasma pools of Chinese origin.
    Ma YY; Guo Y; Zhao X; Wang Z; Lv MM; Yan QP; Zhang JG
    Vox Sang; 2012 Oct; 103(3):183-5. PubMed ID: 22458565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel parvovirus and related variant in human plasma.
    Fryer JF; Kapoor A; Minor PD; Delwart E; Baylis SA
    Emerg Infect Dis; 2006 Jan; 12(1):151-4. PubMed ID: 16494735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
    Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
    J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus PARV4 visualization and detection.
    Tuke PW; Parry RP; Appleton H
    J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
    Maple PA; Beard S; Parry RP; Brown KE
    Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation.
    Fryer JF; Delwart E; Bernardin F; Tuke PW; Lukashov VV; Baylis SA
    J Gen Virol; 2007 Aug; 88(Pt 8):2162-2167. PubMed ID: 17622618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
    Fryer JF; Delwart E; Hecht FM; Bernardin F; Jones MS; Shah N; Baylis SA
    Transfusion; 2007 Jun; 47(6):1054-61. PubMed ID: 17524097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parvovirus PARV4 in clotting factor VIII concentrates.
    Fryer JF; Hubbard AR; Baylis SA
    Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
    Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
    Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
    Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
    New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus 4-like virus in blood products.
    Szelei J; Liu K; Li Y; Fernandes S; Tijssen P
    Emerg Infect Dis; 2010 Mar; 16(3):561-4. PubMed ID: 20202447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step real-time PCR assay for quantitation and genotyping of human parvovirus 4.
    Väisänen E; Lahtinen A; Eis-Hübinger AM; Lappalainen M; Hedman K; Söderlund-Venermo M
    J Virol Methods; 2014 Jan; 195():106-11. PubMed ID: 24134943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of human parvovirus 4 detection in Iran.
    Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
    J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
    Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
    J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
    Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
    PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the inactivation of human parvovirus 4.
    Baylis SA; Tuke PW; Miyagawa E; Blümel J
    Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Parvovirus 4: A harmless bystander or a pathogen of severe acute respiratory illness.
    Prakash S; Shukla S; Ramakrishna V; Mishra H; Bhagat AK; Jain A
    Int J Infect Dis; 2020 Jan; 90():21-25. PubMed ID: 31605808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
    Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
    J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors.
    Lurcharchaiwong W; Chieochansin T; Payungporn S; Theamboonlers A; Poovorawan Y
    Infection; 2008 Oct; 36(5):488-91. PubMed ID: 18759058
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
    Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
    J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.